Pfizer Inc (PFE)

PFE (NYSE:Drugs) EQUITY
$34.29
pos +0.19
+0.56%
Today's Range: 34.07 - 34.40 | PFE Avg Daily Volume: 45,815,400
Last Update: 05/25/16 - 4:04 PM EDT
Volume: 21,015,656
YTD Performance: 5.64%
Open: $34.12
Previous Close: $34.10
52 Week Range: $28.25 - $36.46
Oustanding Shares: 6,064,849,361
Market Cap: 204,203,477,985
6-Month Chart
TheStreet Ratings Grade for PFE
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 8 7 7
Moderate Buy 0 0 0 0
Hold 6 5 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.80 1.77 1.60 1.60
Latest Dividend: 0.30
Latest Dividend Yield: 3.56%
Dividend Ex-Date: 05/11/16
Price Earnings Ratio: 14.58
Price Earnings Comparisons:
PFE Sector Avg. S&P 500
14.58 27.60 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
13.59% -0.53% 17.42%
GROWTH 12 Mo 3 Yr CAGR
Revenue -1.50 -0.20 -0.06
Net Income -23.80 -0.30 -0.10
EPS -21.70 -0.40 -0.17
Earnings for PFE:
EBITDA 18.13B
Revenue 48.85B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $0.63 $0.63 $2.46 $2.64
Number of Analysts 6 4 8 9
High Estimate $0.69 $0.66 $2.51 $2.79
Low Estimate $0.58 $0.61 $2.40 $2.45
Prior Year $0.56 $0.60 $2.20 $2.46
Growth Rate (Year over Year) 11.61% 4.58% 11.65% 7.66%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
By

Skip Raschke

 | May 24, 2016 | 8:30 AM EDT

I prefer a bullish synthetic call.

By

Carleton English

 | May 23, 2016 | 4:35 PM EDT

Investors watching 13F portfolioS for investment clues are reminded to look at a fund's whole portfolio before following too closely in its...

By

Bret Jensen

 | May 17, 2016 | 10:00 AM EDT

It is hard to see much growth in the market overall, until earnings growth returns.

By

Jim Cramer

 | May 16, 2016 | 11:28 AM EDT

Jim Cramer says he wouldn't be surprised if Allergan looked at buying Anacor before Pfizer decided to acquire the company for $5.2 billion, including debt.

By

James Passeri

 | May 16, 2016 | 7:56 AM EDT

Investors rushed to the Palo Alto, Calif.-based drugmaker on news of Pfizer's generous takeover valuation.

By

David Katz

 | May 11, 2016 | 7:00 AM EDT

The expected legal deluge will be manageable thanks to JNJ's massive size and financial strength.

By

Jim Cramer

 | May 10, 2016 | 6:40 AM EDT

And Joe Papa can't stop the world. 

By

Bret Jensen

 | May 9, 2016 | 11:08 AM EDT

And it's hard to get excited about the second quarter, too.

By

Tony Owusu

 | May 3, 2016 | 1:31 PM EDT

U.S. indices were headed lower along with crude prices Tuesday. 

updatePFE Investor Mtg.

Apr 28, 2016 | 7:02 AM EDT

PFE - Pfizer Inc Annual Shareholders Meeting - 8:30AM

Today's strength in ES (Emini S&P 500) ripped above the May 10 high at 2079.75. This i...
Record call volume in Craft Brew Alliance after four day rally. Shares up nearly 5% near $...
Market having another strong day. Energy shares strong as oil tries to broach $50 a barre...
Most Americans seem unhappy with both presumptive presidential candidates. After today's r...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.